JAGSONPAL PHARMACEUTICALS
|
The Current P/E Ratio of JAGSONPAL PHARMACEUTICALS is 28.46.
Share Price | ₹237.0 | May 30,2025 |
Market Cap | ₹1,575.7 Cr | |
Earnings-TTM | ₹55.4 Cr | TTM-Standalone Results |
Price/Earnings | 28.46x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of JAGSONPAL PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹1,575.7 Cr] as on May 30,2025
(/) Earnings [ ₹55.4 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 28.46x ]
Thus, for JAGSONPAL PHARMACEUTICALS , the investors are currently willing to pay 28.46 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of JAGSONPAL PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of JAGSONPAL PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of JAGSONPAL PHARMACEUTICALS
PE Ratio Performance Analysis for JAGSONPAL PHARMACEUTICALS
- JAGSONPAL PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 24.59x.
- JAGSONPAL PHARMACEUTICALS 's operated at median p/e ratio of 28.42x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, JAGSONPAL PHARMACEUTICALS 's p/e ratio peaked in Mar2022 at 43.57x.
- JAGSONPAL PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2020 of 5.81x.
How does JAGSONPAL PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
JAGSONPAL PHARMACEUTICALS | 55.36 | 28.46 | 1,575.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 36.67 | 402,680.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 80.12 | 175,532.0 |
CIPLA LTD | 5,291.05 | 22.36 | 118,315.0 |
TORRENT PHARMACEUTICALS LTD | 1,911.00 | 56.21 | 107,421.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 18.31 | 104,453.0 |
MANKIND PHARMA LTD | 2,003.22 | 50.96 | 102,080.0 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 20.27 | 93,564.7 |
LUPIN LTD | 3,306.26 | 27.05 | 89,439.2 |
AUROBINDO PHARMA LTD | 3,515.26 | 18.96 | 66,647.0 |
ABBOTT INDIA LTD | 1,414.44 | 45.75 | 64,710.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs JAGSONPAL PHARMACEUTICALS 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.31x |
Max industry PE | 80.12x |
Median industry PE | 28.46x |
Average industry PE | 36.83x |
You may also like the below Video Courses